Pre-eclampsia, obesity, and high glucose levels are associated with reduced TAUT activity [53] and induce impairment of fetal growth, with the latter being associated with undesirable outcomes such as obesity, T2D, and an increase in risk of CVD later in adult life [170,171,172]. Here, SLC6A6 is linked to obesity due to melanocortin 4 receptor deficiency.